R

Rainbow Children's Medicare Ltd
NSE:RAINBOW

Watchlist Manager
Rainbow Children's Medicare Ltd
NSE:RAINBOW
Watchlist
Price: 1 363.6 INR -0.98% Market Closed
Market Cap: ₹138.4B

Rainbow Children's Medicare Ltd
Investor Relations

Rainbow Children’s Medicare Ltd runs a network of hospitals focused on child and women’s healthcare in India. It treats newborns, infants, children, and expectant mothers, with services such as maternity care, pediatric consultations, surgeries, intensive care for newborns and children, and related diagnostics and pharmacy support. Its customers are families who need specialized hospital care, especially parents looking for pediatric treatment and women seeking obstetric and maternity services. The company makes money mainly by billing patients and insurers for hospital stays, doctor consultations, procedures, diagnostics, and pharmacy sales. What makes the business different is its narrow focus on pediatrics and maternity rather than general healthcare. That specialization lets it build deep clinical expertise, organize care around mothers and children, and serve a part of the hospital market where trust, emergency capability, and specialized doctors matter a lot.

Show more
Loading...
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q4 2026
Call Date
May 25, 2026
AI Summary
Q4 2026

Strong quarter: Rainbow reported its highest-ever quarterly revenue of INR 459.9 crores, up 24%, with EBITDA of INR 144.7 crores up 26% and PAT of INR 78.2 crores up 38%.

Growth engine: Management said FY '26 was a landmark year, with nearly 500 beds added, and that the new capacity is now starting to show up in performance.

Demand stayed healthy: Inpatient discharges rose 18%, outpatient volumes 19% and deliveries 22% in Q4, while occupancy held at 45.3% despite the large bed additions.

Guidance: The company expects about 20% revenue growth in the current financial year, supported by digital initiatives, marketing, and maturing hospitals.

Balance sheet: Management reiterated that Rainbow has no debt, with cash of about INR 594 crores reported and close to INR 700 crore cash mentioned during Q&A, and said all planned expansions will be funded internally.

Expansion pipeline: Rainbow said it has more than 900 beds in the execution phase, including Coimbatore, Gurugram, Pune, Bangalore, Indore and other projects, most of which should complete over about 2.5 years.

Key Financials
Revenue
INR 459.9 crores
Revenue
INR 1,703 crores
EBITDA
INR 144.7 crores
EBITDA
INR 544 crores
EBITDA Margin
31.5%
EBITDA Margin
32%
PAT
INR 78.2 crores
PAT
INR 282 crores
Occupancy
45.3%
Cash business mix
47.5%
Insurance business mix
around 52%
Liquidity
INR 594 crores
Cash
close to INR 700 crore
Operating cash flow to pre-Ind AS EBITDA
around 92.8%
CapEx
INR 61 crores
CapEx
INR 217 crores
Beds added
nearly 500 beds
Beds in execution
900-plus beds
International patient revenue
INR 28.9 crores
IVF revenue share
3.7%
IVF revenue
INR 61.4 crores
ARPOB growth
about 8%
ALOS
2.7 to 2.8 days
Maintenance CapEx
close to INR 45 crores per year
Other Earnings Calls

Management

Dr. Ramesh Kancharla M. D. Peds
Founder, Chairman, Managing Director and Chief of Gastro Enterology & Hepatology Unit
No Bio Available
Mr. Vikas Maheshwari
Group Chief Financial Officer (KMP)
No Bio Available
Mr. Ashish Kapil
Nodal Officer, Company Secretary & Compliance Officer
No Bio Available
Dr. Dinesh Kumar Chirla (Ped), DM, M.D., MRCPCH (UK)
Whole-Time Director
No Bio Available
Mr. Mahesh Madduri
Head of Strategy
No Bio Available

Contacts

Address
TELANGANA
Hyderabad
Road No - 2, Banjara Hills, Near L V Prasad Eye Hospital,, Next to Hotel Park Hyatt,
Contacts
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett